Mark S. Blumenkranz serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Mark S. Blumenkranz has executed 54 insider transactions totaling $10.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 5, 2014 involved exercising options for 25,000 shares valued at $3.8K.
Mark S. Blumenkranz currently holds 13,091 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark S. Blumenkranz has been a net seller of AAVL stock. They have purchased $0 and sold $10.4M worth of shares.
Mark S. Blumenkranz's most recent insider trade was on Aug 5, 2014, when they sold 25,000 shares at $0.15 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 5, 2014 | AAVL | $0 | Conversion | 12,531 | $N/A | Discretionary |
| Aug 5, 2014 | AAVL | $0 | Conversion | 12,531 | $N/A | Discretionary |